Connection
Holly Wyatt to Anti-Obesity Agents
This is a "connection" page, showing publications Holly Wyatt has written about Anti-Obesity Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.250 |
|
|
|
-
Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, Kim D, Dunayevich E. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013 May; 21(5):935-43.
Score: 0.099
-
Wyatt HR. Update on treatment strategies for obesity. J Clin Endocrinol Metab. 2013 Apr; 98(4):1299-306.
Score: 0.098
-
Wyatt HR, Hill JO. What role for weight-loss medication? Weighing the pros and cons for obese patients. Postgrad Med. 2004 Jan; 115(1):38-40, 43-5, 58.
Score: 0.052